Man among first to receive new Alzheimer s treatment azcentral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azcentral.com Daily Mail and Mail on Sunday newspapers.
FDA approves Alzheimerâs drug Aduhelm, but concerns raised about cost, effectiveness
The controversial, FDA-approved Alzheimerâs treatment has been met with concerns from health officials. In our latest video for Health Insider, Cronkite new breaks down what you should know about the new drug Aduhelm.
By: Jamie Landers and Gianluca DâElia, Cronkite News
Posted at 3:56 PM, Jul 21, 2021
and last updated 2021-07-21 18:56:18-04
For the first time since 2003, the Federal Drug Administration has approved a new treatment for Alzheimerâs disease, a progressive brain disorder that affects roughly 6 million people in the United States and is projected to affect more than 13 million by 2050.
Arizona PBS
PHOENIX – For the first time since 2003, the Federal Drug Administration has approved a new treatment for Alzheimer’s disease, a progressive brain disorder that affects roughly 6 million people in the United States and is projected to affect more than 13 million by 2050.
Last year, there were at least 42,000 more deaths from Alzheimer’s disease and other dementias in the U.S. – a 16% increase over the average of the preceding five years, according to an analysis of federal data by the Alzheimer’s Association.
The new drug, Aduhelm, is given intravenously once a month. It wasn’t designed to be a cure, but rather aims to reduce brain damage and preserve cognitive function.